Medscape: GLP-1s Tied to Lower Cancer Risk in Patients With Obesity
The post Medscape: GLP-1s Tied to Lower Cancer Risk in Patients With Obesity appeared first on UNC Lineberger Comprehensive Cancer Center .
Read the full articleYou might also wanna read
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
forbes.com·26d ago
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.
mdsc.pe·14d ago
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those takin
Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels
People's daily steps might drop after starting a GLP-1 prescription, new research suggests.
gizmodo.com·25d ago
Experts warn easy access to GLP-1 drugs may increase eating disorder risks
With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are
mdsc.pe·20d ago
GLP-1 and weight-loss drugs: How fast-track health solutions are reshaping FMCG
GLP-1 weight-loss drugs are reshaping FMCG as health, body control, and self-optimization trends redefine consumer behaviour across Europe.
Comments
Sign in to join the conversation.
No comments yet. Be the first.